Format
Items per page
Sort by

Send to:

Choose Destination

Links from

Items: 1 to 20 of 902

1.

Botulinum toxin injections for adults with overactive bladder syndrome.

Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD005493. doi: 10.1002/14651858.CD005493.pub3. Review.

PMID:
22161392
2.

Botulinum toxin injections for adults with overactive bladder syndrome.

Duthie J, Wilson DI, Herbison GP, Wilson D.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005493. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD005493.

PMID:
17636801
3.

Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.

Rai BP, Cody JD, Alhasso A, Stewart L.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD003193. doi: 10.1002/14651858.CD003193.pub4. Review.

PMID:
23235594
4.

Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.

Utomo E, Groen J, Blok BF.

Cochrane Database Syst Rev. 2014 May 24;5:CD004927. doi: 10.1002/14651858.CD004927.pub4. Review.

PMID:
24859260
5.

OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Chapple C, Sievert KD, MacDiarmid S, Khullar V, Radziszewski P, Nardo C, Thompson C, Zhou J, Haag-Molkenteller C.

Eur Urol. 2013 Aug;64(2):249-56. doi: 10.1016/j.eururo.2013.04.001. Epub 2013 Apr 10.

PMID:
23608668
6.

Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature.

Anger JT, Weinberg A, Suttorp MJ, Litwin MS, Shekelle PG.

J Urol. 2010 Jun;183(6):2258-64. doi: 10.1016/j.juro.2010.02.009. Epub 2010 Apr 18. Review.

7.

Botulinum toxin type B for cervical dystonia.

Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004315. Review.

PMID:
15674941
8.

Intravesical treatments for painful bladder syndrome/ interstitial cystitis.

Dawson TE, Jamison J.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006113. Review.

PMID:
17943887
9.

Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults.

Alhasso AA, McKinlay J, Patrick K, Stewart L.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003193. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD003193.

PMID:
17054163
10.

Botulinum toxin-A injections for idiopathic overactive bladder: a systematic review and meta-analysis.

Cui Y, Wang L, Liu L, Zeng F, Niu J, Qi L, Chen H.

Urol Int. 2013;91(4):429-38. doi: 10.1159/000351037. Epub 2013 Aug 16. Review.

PMID:
23970316
11.

Which anticholinergic drug for overactive bladder symptoms in adults.

Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD005429. doi: 10.1002/14651858.CD005429.pub2. Review.

PMID:
22258963
12.

[Botulinum toxin injection for refractory non-neurogenic overactive bladder. Systematic review].

Henriet B, Roumeguère T.

Rev Med Brux. 2015 Jan-Feb;36(1):29-37. Review. French.

PMID:
25856969
13.

Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial.

Chuang YC, Kaufmann JH, Chancellor DD, Chancellor MB, Kuo HC.

J Urol. 2014 Dec;192(6):1743-9. doi: 10.1016/j.juro.2014.07.008. Epub 2014 Jul 18.

PMID:
25046622
14.
15.

Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study).

Tincello DG, Kenyon S, Abrams KR, Mayne C, Toozs-Hobson P, Taylor D, Slack M.

Eur Urol. 2012 Sep;62(3):507-14. doi: 10.1016/j.eururo.2011.12.056. Epub 2012 Jan 5.

PMID:
22236796
16.

Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.

Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003781. Review.

PMID:
17054185
17.

Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder.

Kantartzis K, Shepherd J.

Curr Opin Obstet Gynecol. 2012 Oct;24(5):331-6. doi: 10.1097/GCO.0b013e3283573ff9. Review.

PMID:
22922403
18.

Botulinum toxin and refractory non-neurogenic overactive detrusor.

Ksibi I, Godard AL, Azouvi P, Denys P, Dziri C.

Ann Phys Rehabil Med. 2009 Nov;52(9):668-83. doi: 10.1016/j.rehab.2009.07.032. Epub 2009 Aug 13. Review.

19.

Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates.

Dowson C, Watkins J, Khan MS, Dasgupta P, Sahai A.

Eur Urol. 2012 Apr;61(4):834-9. doi: 10.1016/j.eururo.2011.12.011. Epub 2011 Dec 13.

PMID:
22204745
20.

Botulinum toxin type A therapy for blepharospasm.

Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004900. Review.

PMID:
15674969
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk